Antimicrobial peptides (AMPs), including cathelicidins and defensins are host defence peptides that carry out multiple roles in the gastrointestinal (GI) tract. Antimicrobial Peptides in Gastrointestinal Diseases presents knowledge about the physiological functions and pharmacological actions of AMPs in inflammation, cancer, and further infection of the GI tract. The book provides coverage from the basic research to clinical application for GI diseases. Current research and development of AMPs is presented, opening the way for further work on these peptides, not only in the context of GI diseases, but also for similar pathologies in other organs. AMPs are key to the regulation of human microbiome and second line defence in the GI mucosa, prevent colonization of pathogens and modulation of innate response to invading pathogens, and modify immunological reactions during inflammatory processes and oncogenic development in the GI mucosa. More importantly, AMPs possess diversified anti-microbial actions against various infectious diseases in the GI tract. With these physiological functions and pharmacological actions, AMPs have significant potential as therapeutic agents for the treatment of inflammation, cancer and further infection in the GI tract.
1. General Introduction of Antimicrobial Peptides and Gastrointestinal Diseases - p. xi 2. Chapter 1: Regulation of Cationic Antimicrobial Peptides Expression in the Digestive Tract - p. xii 3. Chapter 2: Antimicrobial Peptides in the Host-Microbiota Homeostasis - p. 20 4. Chapter 3: The Roles of Antimicrobial Peptides in the Regulation of Gastrointestinal Microbiota and Innate Immunity - p. 33 5. Chapter 4: Cathelicidin in Gastrointestinal Disorders - p. 60 6. Chapter 5: Antimicrobial Peptides as Potential Therapy for Gastrointestinal Cancers: Opportunities and Challenges - p. 76 7. Chapter 6: AMPs and Mechanisms of Antimicrobial Action - p. 96 8. Chapter 7: Host Defense Peptides as Innate Immunomodulators in the Pathogenesis of Colitis - p. 131 9. Chapter 8: Conclusion - p. 164 10. Index - p. 169
Antimicrobial peptides (AMPs), including cathelicidins and defensins are host defence peptides that carry out multiple roles in the gastrointestinal (GI) tract. Antimicrobial Peptides in Gastrointestinal Diseases presents knowledge about the physiological functions and pharmacological actions of AMPs in inflammation, cancer, and further infection of the GI tract. The book provides coverage from the basic research to clinical application for GI diseases. Current research and development of AMPs is presented, opening the way for further work on these peptides, not only in the context of GI diseases, but also for similar pathologies in other organs. AMPs are key to the regulation of human microbiome and second line defence in the GI mucosa, prevent colonization of pathogens and modulation of innate response to invading pathogens, and modify immunological reactions during inflammatory processes and oncogenic development in the GI mucosa. More importantly, AMPs possess diversified anti-microbial actions against various infectious diseases in the GI tract. With these physiological functions and pharmacological actions, AMPs have significant potential as therapeutic agents for the treatment of inflammation, cancer and further infection in the GI tract.
1. General Introduction of Antimicrobial Peptides and Gastrointestinal Diseases - p. xi 2. Chapter 1: Regulation of Cationic Antimicrobial Peptides Expression in the Digestive Tract - p. xii 3. Chapter 2: Antimicrobial Peptides in the Host-Microbiota Homeostasis - p. 20 4. Chapter 3: The Roles of Antimicrobial Peptides in the Regulation of Gastrointestinal Microbiota and Innate Immunity - p. 33 5. Chapter 4: Cathelicidin in Gastrointestinal Disorders - p. 60 6. Chapter 5: Antimicrobial Peptides as Potential Therapy for Gastrointestinal Cancers: Opportunities and Challenges - p. 76 7. Chapter 6: AMPs and Mechanisms of Antimicrobial Action - p. 96 8. Chapter 7: Host Defense Peptides as Innate Immunomodulators in the Pathogenesis of Colitis - p. 131 9. Chapter 8: Conclusion - p. 164 10. Index - p. 169
